Deal Ticker: Kellerhals Carrard advises Broadview Ventures and Panakes Partners in the EUR 44 million Series B Financing Round of CorFlow Therapeutics

We are thrilled to have advised Broadview Ventures Inc and Panakes Partners in leading the EUR 44 million Series B financing round of CorFlow Therapeutics! This round also includes participation from Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners, M&L INVESTMENTS, L.C., Unorthodox Ventures, Kofa Healthcare and Monte Carlo Capital, with continued support from 415 Capital, CorFlow's initial VC investor and largest shareholder. 

The Series B will allow the company to advance a novel diagnostic and drug delivery platform for microvascular obstruction (MVO) in heart attack patients.

We feel grateful for the feedback that David Prim, PhD, of Broadview Ventures, newly appointed member to CorFlow’s board of directors, shared with us:

“The KC team diligently represented Broadview Ventures and Panakes Partners as co-lead investors, while being responsive and friendly to work with. As US-based investors, we at Broadview Ventures were less familiar with the nuances of Swiss law, and we appreciated the extent to which Umberto, Karim, and the KC team advised us on the specifics of the law as well as common practices in comparable Swiss transactions. Their expertise was much appreciated.”

It's been a privilege to work with you and to accompany you in this journey! We wish Broadview Ventures and Panakes Partners a successful collaboration with the company and look forward to witnessing your continued success as CorFlow validates its CoFl system.

The Kellerhals Carrard team was co-led by Karim Maizar (Partner, VC/M&A) and Umberto Milano (Senior Associate, VC/M&A) and further included Céline Schmid (Senior Associate, Employment), Vera Vallone (Associate, IP) and Melissa Wiss (Paralegal).

Here’s to many more achievements ahead! 🌟

#ThisIsKellerhalsCarrard #DealTicker #BroadviewVentures #PanakesPartners #SeriesBFunding #MVO #STEMI #HeartAttack #Precision #UnmetNeed #CorFlow